LYMPHOID TISSUE HYPOPLASIA

LYMPHOID TISSUE HYPOPLASIA was reported 153 times

LYMPHOID TISSUE HYPOPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Asparagine-specific Enzyme [EPC] 78 0.0058
1 Topoisomerase Inhibitor [EPC] 148 0.0019
2 Provitamin D2 Compound [EPC] 34 0.0011
3 Leukocyte Growth Factor [EPC] 149 0.0010
4 Echinocandin Antifungal [EPC] 7 0.0009
5 Calcineurin Inhibitor Immunosuppressant [EPC] 97 0.0007
6 Serotonin-3 Receptor Antagonist [EPC] 88 0.0006
7 Alkylating Drug [EPC] 143 0.0006
8 Nucleoside Metabolic Inhibitor [EPC] 148 0.0005
9 Xanthine Oxidase Inhibitor [EPC] 88 0.0005
10 Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] 1 0.0003
11 Loop Diuretic [EPC] 88 0.0002
12 Folate Analog Metabolic Inhibitor [EPC] 69 0.0002
13 Corticosteroid [EPC] 147 0.0001
14 Osmotic Laxative [EPC] 31 0.0001
15 Purine Antimetabolite [EPC] 2 0.0000
16 Calcium [EPC] 1 0.0000
17 Vitamin D [EPC] 1 0.0000
18 Vitamin B12 [EPC] 1 0.0000
19 Vitamin C [EPC] 1 0.0000
20 Tumor Necrosis Factor Blocker [EPC] 1 0.0000